The ValueCare Group
 | |
| Founded | 2024 |
|---|---|
| Headquarters | , |
| Services | Life Sciences and Health Technologies |
| Website | https://www.thevaluecaregroup.co.uk/ |
The ValueCare Group is a British company established in 2024, specializing in the development of health technology and the application of life sciences.[1]
Headquartered at the Level39 technology accelerator in Canary Wharf, London, the company focuses on creating artificial intelligence (AI)-powered systems for the health and social care sectors. Its stated mission is to build scalable care infrastructure designed to address systemic pressures exacerbated by global trends such as aging populations and the increasing prevalence of chronic diseases. The company aims to provide platforms that can be deployed across both public and private healthcare organizations.
History and focus
Founded in 2024, The ValueCare Group was established to address challenges in existing healthcare systems. The company describes these challenges as part of the 'structural collapse of legacy care models. The company highlights issues such as avoidable hospital admissions, delayed patient discharges, and healthcare workforce shortages as key areas its technology seeks to address. Rather than solely acting as a technology vendor, ValueCare positions itself as developing an "infrastructure replacement layer" intended to improve the stability, automation, and efficiency of care delivery.
Since its inception, the company reports deployments of its technology within various UK healthcare settings and participation in NHS-led research trials aimed at validating the efficacy and impact of its systems.[2]
Key strategic developments include securing an investment partnership with Oxford University Hospitals NHS Foundation Trust, which reportedly involves collaborative research and development efforts. ValueCare has also received support from and participated in programs with Innovate UK, the UK's national innovation agency; NVIDIA Inception, a program for AI startups; and Barclays Eagle Labs, a business incubator network.
The ValueCare Group is a listed supplier on UK public sector procurement frameworks, including the Crown Commercial Service and the NHS Supply Chain, facilitating its engagement with public healthcare providers. The company has publicly stated its strategic intention to expand its operations into the United States market and is reportedly exploring and securing investment partnerships in the US to support this international growth.[3]
Technology and products
ValueCare develops AI-driven platforms that leverage Internet of Things (IoT) connectivity for data acquisition from in-home devices and employ advanced data analytics, including predictive modelling, for preventative and personalized care. The company holds trademarks for its MICA and MILIE product lines.
MICA
MICA, an acronym for My Intelligent Care Assistant, is a conversational AI care wearable device presented in the form of a wristwatch.[4] The ValueCare Group describes MICA as the first system of its kind developed in the UK specifically for healthcare applications. The company states that MICA utilizes a unique technical approach by integrating multiple large language models (LLMs) to enable real-time, natural language conversations between the user and the AI.
The MICA device allows users to vocally log their health condition, communicate their emotional state, and receive personalized prompts and medication or appointment reminders.[5]Data captured by the wearable is synchronized in real-time to a secure, cloud-based monitoring dashboard. This dashboard is accessible to authorized individuals, such as family members or designated clinical teams, providing them with continuous insight into the user's status. The system is designed to facilitate proactive, user-led health reporting and engagement, offering an alternative to traditional reactive telecare systems like pendant alarms.
MILIE
MILIE is a software platform described as a fully integrated virtual ward and care coordination system, designed for national and potentially international scale deployment. It functions as a hardware-agnostic care infrastructure layer, capable of connecting with a variety of in-home sensors and medical devices. The platform processes incoming data using predictive analytics and workflow automation tools.
The company states that MILIE employs a patent-pending, edge-first system architecture. This approach is intended to process data closer to the source, aiming to significantly reduce cloud bandwidth consumption and data transmission latency, which can be critical for real-time monitoring and intervention. MILIE is designed to support a range of clinical pathways, including hospital discharge management, remote patient monitoring for chronic conditions, reablement programs to support patient recovery and independence, and the early detection of patient decline through continuous algorithmic analysis of health data. The platform aims to enable healthcare providers to reduce operational overheads and improve patient outcomes.
Recognition and collaborations
In 2025, The ValueCare Group received an award, cited as "AI Health Innovation of the Year" by Health Tech World. This recognition was reportedly for the national relevance and technical sophistication of its platforms.[6]The company and its technologies have been featured in various industry-specific innovation briefings and healthcare investment forums.[7] Its work is cited in contexts relating to advancing health span support, enhancing national healthcare resilience, and contributing to the development of digital-first public health infrastructure. The company actively collaborates with NHS organizations, participating in research trials to gather evidence on the clinical and economic benefits of its systems.
References
- ↑ "The ValueCare Group Ltd". 1 November 2024.
- ↑ "Delegate Pack - SWL Health Research Summit". Big Knowledge. Retrieved 2025-06-06.
- ↑ "#thevaluecaregroup #smartercarebetteroutcomes #healthtechuk… | The ValueCare Group". www.linkedin.com. Retrieved 2025-06-06.
- ↑ Davies, Robert (2025-02-27). "A Defining Moment for Digital Health: London Startup Unveils the UK's First Conversational AI Wearable, Ushering in a New Era of Proactive Care". Big Knowledge. Retrieved 2025-06-05.
- ↑ Sarsby, Sarah (2025-03-04). "New digital health tech enables local authorities to take a proactive approach to care for better outcomes". AT Today - Assistive Technology. Retrieved 2025-06-06.
- ↑ "Health Tech World Awards 2025: Winners revealed". www.htworld.co.uk. 2025-05-08. Retrieved 2025-06-05.
- ↑ www.duodesign.co.uk. "TSA A Defining Moment for Digital Health: London Startup Unveils the UK's First Conversational AI Wearable, Ushering in a New Era of Proactive Care". TSA. Retrieved 2025-06-06.
External links
- The ValueCare Group – Official website
- The ValueCare Group on LinkedIn – Expansion and Strategic Goals
- The ValueCare Group on LinkedIn – Podcasts Featuring the Group
- The ValueCare Group on LinkedIn – Work in South West London
This article "The ValueCare Group" is from Wikipedia. The list of its authors can be seen in its historical and/or the page Edithistory:The ValueCare Group. Articles copied from Draft Namespace on Wikipedia could be seen on the Draft Namespace of Wikipedia and not main one.
